Tsuei-Ju Wu - Concepedia

Concepedia

Author

Tsuei-Ju Wu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Tsuei-Ju Wu, Tsuei-ju Wu, TsueiJu Wu

13

Publications

1.9K

Citations

12

H-Index

39

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Arena Pharmaceuticals (United States)

TW

About

Tsuei-Ju Wu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	674
2	Natural Sciences	5	5	200
3	Biochemistry	4	4	182
4	Health Sciences	1	1	74
5	Allergy	1	1	113

Tsuei-Ju Wu

×

13

Publications

1.9K

Citations

12

H-Index

	Year	Citations
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan, Journal of Biological Chemistry	2005	636
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng, The Journal of Experimental Medicine	2005	362
Antagonism of the prostaglandin D <sub>2</sub> receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans Kang Cheng, Tsuei-Ju Wu, Kenneth K. Wu, Proceedings of the National Academy of Sciences InflammationMolecular PharmacologySignal TransductionMolecular PhysiologyMedicine	2006	268
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2 Lihu Yang, Scott C. Berk, Susan P. Rohrer, Proceedings of the National Academy of Sciences	1998	128
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression Brett Lauring, Andrew K.P. Taggart, James R. Tata, Science Translational Medicine	2012	125
Immune Enhancing Effect of a Growth Hormone Secretagogue Gloria C. Koo, Christopher Huang, Ramon E. Camacho, The Journal of Immunology Gh SecretagogueGrowth HormoneAutoimmune DiseaseAllergyHuman Growth	2001	113
Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats Hong C. Shen, Fa‐Xiang Ding, Qiaolin Deng, Journal of Medicinal Chemistry Tricyclic AnaloguesMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2009	78
Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor Kenneth K. Wu, Tsuei-Ju Wu, Jayne Chin, Atherosclerosis InflammationMetabolic SyndromeLipid DisorderOxysterolCardiovascular Disease	2005	74
Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate Hong C. Shen, Fa‐Xiang Ding, Subharekha Raghavan, Journal of Medicinal Chemistry Potent Niacin ReceptorExcellent Receptor ActivityPharmacotherapyExperimental PharmacologyMedicinal Chemistry	2010	57
Discovery of Biaryl Anthranilides as Full Agonists for the High Affinity Niacin Receptor Hong C. Shen, Fa‐Xiang Ding, Silvi Luell, Journal of Medicinal Chemistry Drug TargetImmunologyPharmacotherapyMedicinal ChemistryReceptor Gpr109a	2007	36

Page 1